Pulmonary Disease Doctors in Evansville, IN Accepting Medicare

14 Pulmonary Disease doctors found. Showing 1 - 14

Dr. Tameem Al-aqtash, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Dr. Roy Mason Arnold, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 525 Audubon Dr, Evansville, IN 47715 Phone: 812-746-9945

Dr. Dan Vardi, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Dr. Robert Kenneth Spear Jr., M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 420 Mulberry St, Evansville, IN 47713 Phone: 812-435-2459    Fax: 812-435-5468

Ahmed Jawad, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Arthur Bentsen, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Khawaja Ahmed Salman Zaki, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Daniel W. Henry, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Dr. Matthew Alva Tucker, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Raghav Gupta, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Dr. Victor M Chavez, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Saint Marys Dr, Suite 200, Evansville, IN 47714 Phone: 812-485-6030    Fax: 812-485-6032

David L S Ryon, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

Dr. Peter A Rosario, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 901 Saint Marys Dr, Suite 200, Evansville, IN 47714 Phone: 812-485-6030    Fax: 812-485-6032

David T. Harris, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 Harriet St, Evansville, IN 47710 Phone: 812-450-7720    Fax: 812-450-7730

News Archive

New strategies may improve performance of CAR-T cell therapy in treating cancer

Mayo Clinic researchers have developed two new strategies that may improve the performance of chimeric antigen receptor therapy in treating cancer. They are presenting results of their preclinical research at the 2018 annual meeting of the American Society of Hematology in San Diego.

Over 20% of women are paying out-of-pocket costs for their screening mammogram, shows study

More than 20% of women aged 50-64 years and those aged 65-74 years with Medicare coverage reported paying out-of-pocket costs for their most recent screening mammogram, according to a study led by researchers from the Centers for Disease Control and Prevention.

New technique to study genetic changes could enhance cancer diagnosis

Large-scale changes to the structure of the genome are often seen in cancer cells. Scientists at the Babraham Institute in Cambridge, UK, have found a way to detect these changes, which could enhance cancer diagnosis and aid the use of targeted treatments.

Positive interim anemia response data from YM's CYT387 Phase I/II trial in myelofibrosis

YM BioSciences Inc., today announced that updated interim anemia response data were reported for the first 60 patients enrolled in the Phase I/II trial of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.

Read more Medical News

› Verified 5 days ago